Geftinat 250mg Gefitinib Tablets

Geftinat 250mg Gefitinib Tablets

3200/Bottle INR

Product Details:

  • Drug Type Specific Drug
  • Physical Form Tablets
  • Dosage 250 mg
  • Suitable For Adults, Women
  • Supply Ability : 10000000 Piece Per Week
  • Click to view more
X

Price And Quantity

  • 3200/Bottle INR
  • 10000000 Piece

Product Specifications

  • Specific Drug
  • Adults, Women
  • 250 mg
  • Tablets

Trade Information

  • Cash in Advance (CID), Cash Advance (CA)
  • 10000000 Piece Per Week
  • 1 Week
  • Africa, Middle East, Western Europe, Eastern Europe, South America, North America, Central America, Australia, Asia

Product Description

 Geftinat - IRESSA® (Geftinat tablets) contain 250 mg of Geftinat and are available as brown film-coated tablets for daily oral administration. IRESSA is indicated as monotherapy for the treatment of patients with locally advanced or metastatic non-small cell lung cancer after failure of both platinum-based and docetaxel chemotherapies. The effectiveness of IRESSA is based on objective response rates (see CLINICAL PHARMACOLOGY — Clinical Studies section). There are no controlled trials demonstrating a clinical benefit, such as improvement in disease-related symptoms or increased survival. Results from two large, controlled, randomized trials in first-line treatment of non-small cell lung cancer showed no benefit from adding IRESSA to doublet, platinum-based chemotherapy. Therefore, IRESSA is not indicated for use in this setting. Active ingredients: Gefitinib

DHEER HEALTHCARE PRIVATE LIMITED

* Tips on getting accurate quotes. Please include product name, order quantity, usage, special requests if any in your inquiry.

SEND INQUIRY CALL ME FREE


DHEER HEALTHCARE PRIVATE LIMITED All Rights Reserved.(Terms of Use)
Developed and Managed by Infocom Network Ltd.